References
- Artan M, Li Y, Karadeniz F, Lee SH, Kim MM, Kim SK (2008) Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava. Bioorgan Med Chem 16(17):7921-7926 https://doi.org/10.1016/j.bmc.2008.07.078
- Blois MS (1955) A note on free radical formation in biologically occurring quinones. Biochim Biophys Acta 18:165 https://doi.org/10.1016/0006-3002(55)90038-X
- Brossi A (1990) Bioactive alkaloids. 4. results of recent investigations with colchicine and physostigmine. J Med Chem 33:2311-2319 https://doi.org/10.1021/jm00171a001
- Choi BW, Lee HS, Shin HC, Lee BH (2015) Multifunctional activity of polyphenolic compounds associated with a potential for alzheimer's disease therapy from Ecklonia cava. Phytother Res 29:549-553 https://doi.org/10.1002/ptr.5282
- Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, Edwards S, Hardyman W, Raftery J, Crome P, Lendon C, Shaw H, Bentham P (2004) AD2000 collaborative group. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 363(9427):2105-2115 https://doi.org/10.1016/S0140-6736(04)16499-4
- Cummings JL (2000) Cholinesterase inhibitors: a new class of psychotropic compounds. Am J Psychiatry 157:4-15 https://doi.org/10.1176/ajp.157.1.4
- Drachman DA, Leavitt J (1974) Human memory and the cholinergic system. A relationship to ageing? Arch Neurol 30:113-121 https://doi.org/10.1001/archneur.1974.00490320001001
- Ellmans GL, Courtney KD, Andress VJ, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95 https://doi.org/10.1016/0006-2952(61)90145-9
- Giacobini E (2000) Cholinesterases and cholinesterase inhibitors. Martin Dunitz Ltd, London, 280 p
- Greig NH, Pei X-F, Soncrant TT, Ingram DK, Brossi A (1995) Phenserine and ring C hetero-analogs: drug candidates for the treatment of Alzheimer's disease. Med Res Rev 15(1):3-31 https://doi.org/10.1002/med.2610150103
- Greig NH, Utsuki T, Yu Q, Zhu X, Holloway HW, Perry T, Lee BH, Ingram DK, Lahiri DK (2001) A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase. Curr Med Res Opin 17(2):1-6 https://doi.org/10.1185/03007990152005397
- Greig NH, Sambamurti K, Yu QS, Perry TA, Holloway HW, Haberman F, Brossi A, Ingram DK, Lahiri DK (2003) Butyrylcholinesterase: its selective inhibition and relevance to Alzheimer's disease. In: Giacobini E (ed) Its Function and Inhibition. Martin Dunitz Ltd, London, pp 69-90
-
Greig NH, Utsuki T, Ingram DK, Wang Y, Pepeu G, Scali C, Yu QS, Mamczarz J, Holloway HW, Giordano T, Chen D, Furukawa K, Sambamurti K, Brossi A, Lahiri DK (2005a) Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer
${\beta}$ -amyloid peptide in rodent. P Natl Acad Sci 102:17213-17218 https://doi.org/10.1073/pnas.0508575102 - Greig NH, Sambamurti K, Yu QS, Brossi A, Bruinsma G, Lahiri DK (2005b) An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Curr Alzherimer Res 2:281-291 https://doi.org/10.2174/1567205054367829
- Hirase S, Araki C, Watanabe (1967) Component sugars of the polysaccharide of the red seaweed Grateloupia elliptica. B Chem Soc Jpn 40(6):1445-1448 https://doi.org/10.1246/bcsj.40.1445
- Kim KY, Nam KA, Kurihara H, Kim SM (2008) Potent alpha-glucosidase inhibitors purified from the red alga Grateloupia elliptica. Phytochemistry 69:2820-2825 https://doi.org/10.1016/j.phytochem.2008.09.007
- Lahiri DK, Rogers JT, Sambamurti K, Greig NH (2004) Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents. Curr Pharm Design 10:3111-3119 https://doi.org/10.2174/1381612043383331
- Lee MS, Shin T, Utsuki T, Choi JS, Byun DS, Kim HR (2012) Isolation and identification of phlorotannins from Ecklonia stolonifera with antioxidant and hepatoprotective properties in Tacrine-Treated HepG2 cells. J Agric Food Chem 60(21):5340-5349 https://doi.org/10.1021/jf300157w
- Liu JY (2008) Checklist of biota of Chinese seas. China Science Press, Beijing, 1267 p
- Liu JS, Zhu YL, Yu CM, Zhou YZ, Han YY, Wu FW, Qi BF (1986) The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity. Can J Chemistry 64(4):837-839 https://doi.org/10.1139/v86-137
- Lopez OL, Becker JT, Saxton J, Sweet RA, Klunk W, DeKosky ST (2005) Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition. J Am Geriatr Soc 53:83-87 https://doi.org/10.1111/j.1532-5415.2005.53015.x
- Sambamurti K, Greig NH, Lahiri DK (2002) Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease. Neuromol Med 1:1-31 https://doi.org/10.1385/NMM:1:1:1
- Sambamurti K, Suram A, Venugopal C, Prakasam A, Zhou Y, Lahiri DK, Greig NH (2006) A partial failure of membrane protein turnover may cause Alzheimer's disease: a new hypothesis. Curr Alzherimer Res 3:81-90 https://doi.org/10.2174/156720506775697142
- Selkoe DJ (2005) Defining molecular targets to prevent Alzheimer disease. Arch Neurol 62(2):192-195 https://doi.org/10.1001/archneur.62.2.192
- Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286(5440):735-741 https://doi.org/10.1126/science.286.5440.735
- Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286(5440):735-741 https://doi.org/10.1126/science.286.5440.735
- Walker LC, Rosen RF (2006) Alzheimer therapeutics-what after the cholinesterase inhibitors? Age and Ageing 35(4):332-335 https://doi.org/10.1093/ageing/afl009
- Yu QS, Holloway HW, Utsuki T, Brossi A, Greig NH (1999) Synthesis of novel phenserine-based selective inhibitors of butyrylcholinesterase for Alzheimer's disease. J Med Chem 42(10):1855-1861 https://doi.org/10.1021/jm980459s